{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T05:18:01Z","timestamp":1712985481592},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Continuous long-term treatment is recommended to reduce the hepatitis B virus (HBV) viral load. However, as a consequence, resistance mutations can emerge and be transmitted to other individuals. The polymerase (POL) gene overlaps the surface (S) gene. Thus, during treatment, mutations in the POL gene may lead to changes in hepatitis B surface antigen (HBsAg). The purpose of this study was to evaluate the frequency of lamivudine and vaccine escape mutations in HBsAg-positive blood donors from the city of Santos and in untreated HBV mono-infected patients from the city of S\u00e3o Paulo, Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HBV DNA was extracted from 80 serum samples, of which 61 were from volunteer blood donors and 19 were from untreated HBV patients. A fragment of the POL\/S genes containing 593 base pairs was amplified using nested PCR. Thirty four were PCR-positive and sequencing was performed using an ABI Prism 3130 Genetic Analyzer. Alignments and mutation mapping were performed using BioEdit software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>HBV DNA from 21 blood donors and 13 untreated patient samples were characterized using nucleotide sequencing PCR products from the POL\/S genes. We were able to detect one sample with the resistance mutation to lamivudine rtM204V\u2009+\u2009rtL180M (2.94%), which was found in a volunteer blood donor that has never used antiviral drugs. The other samples showed only compensatory mutations, such as rtL80F (5.88%), rtL80V (2.94%), rtL82V\u2009+\u2009rtV207L (2.94%), rtT128P (5.88%), rtT128N\/S (2.94%) and rtS219A (5.88%). We found modifications in the S gene in 14 of the 34 samples (41.16%). The mutations detected were as follows: sM133L\u2009+\u2009sI195T (2.94%), sI195M (2.94%), sP120T (2.94%), sY100S\/F (2.94%), sY100C (17.64%), sI\/T126P\u2009+\u2009sQ129P (2.94%), sM198I\u2009+\u2009sF183C (2.94%) and sS210R (5.88%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results suggest the transmission of lamivudine-resistant forms. Thus, the evaluation of HBV-infected subjects for lamivudine resistance would improve treatment regime. Moreover, the mutations in the S gene may impair HBsAg antigenicity and contribute to HBsAg failure detection and vaccine escape.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-10-320","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T14:01:28Z","timestamp":1382968888000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and S\u00e3o Paulo, Brazil"],"prefix":"10.1186","volume":"10","author":[{"given":"Nathalia","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Claudio","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane Pereira","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Roberto Ferreira","family":"Abr\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Sobhie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Montani","family":"Caseiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley Vasconcelos","family":"Komninakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12072-008-9048-3","volume":"2","author":"S Locarnini","year":"2008","unstructured":"Locarnini S: Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure. Hepatol Int 2008, 2: 147-151. 10.1007\/s12072-008-9048-3","journal-title":"Hepatol Int"},{"key":"2582_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jac\/dki457","volume":"57","author":"C Alvarado-Esquivel","year":"2006","unstructured":"Alvarado-Esquivel C, de la Ascension C-GM, Conde-Gonzalez CJ, Juarez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S, Torres-Valenzuela A, Sablon E: Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico. J Antimicrob Chemother 2006, 57: 221-223. 10.1093\/jac\/dki457","journal-title":"J Antimicrob Chemother"},{"key":"2582_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jcv.2005.08.004","volume":"35","author":"M Horgan","year":"2006","unstructured":"Horgan M, Brannigan E, Crowley B, Levis J, Fanning LJ: Hepatitis B genotype and YMDD profiles in an untreated Irish population. J Clin Virol 2006, 35: 203-204. 10.1016\/j.jcv.2005.08.004","journal-title":"J Clin Virol"},{"key":"2582_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0213-005X(04)73051-7","volume":"22","author":"P Leon","year":"2004","unstructured":"Leon P, Pozo F, Echevarria JM: Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain. Enferm Infecc Microbiol Clin 2004, 22: 133-137.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2582_CR5","first-page":"99","volume":"19","author":"S Tuncbilek","year":"2008","unstructured":"Tuncbilek S, Kose S, Elaldi A, Akman S: Lamivudine resistance in untreated chronic hepatitis B patients in Turkey. Turk J Gastroenterol 2008, 19: 99-103.","journal-title":"Turk J Gastroenterol"},{"key":"2582_CR6","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","volume":"77","author":"WE Delaney","year":"2003","unstructured":"Delaney WE, Yang H, Westland CE, Das K, Arnold E, Gibbs CS, Miller MD, Xiong S: The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 2003, 77: 11833-11841. 10.1128\/JVI.77.21.11833-11841.2003","journal-title":"J Virol"},{"key":"2582_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/viro.2001.1246","volume":"293","author":"J Torresi","year":"2002","unstructured":"Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, Locarnini SA, Fyfe J, Sozzi T, Jackson DC: Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 2002, 293: 305-313. 10.1006\/viro.2001.1246","journal-title":"Virology"},{"key":"2582_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2180-7-103","volume":"7","author":"FC Mello","year":"2007","unstructured":"Mello FC, Souto FJ, Nabuco LC, Villela-Nogueira CA, Coelho HS, Franz HC, Saraiva JC, Virgolino HA, Motta-Castro AR, Melo MM, et al.: Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. BMC Microbiol 2007, 7: 103. 10.1186\/1471-2180-7-103","journal-title":"BMC Microbiol"},{"key":"2582_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.virusres.2007.02.021","volume":"127","author":"A Kay","year":"2007","unstructured":"Kay A, Zoulim F: Hepatitis B virus genetic variability and evolution. Virus Res 2007, 127: 164-176. 10.1016\/j.virusres.2007.02.021","journal-title":"Virus Res"},{"key":"2582_CR10","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/S0006-2952(98)00050-1","volume":"55","author":"L Fu","year":"1998","unstructured":"Fu L, Cheng YC: Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(\u2212)SddC (3TC) resistance. Biochem Pharmacol 1998, 55: 1567-1572. 10.1016\/S0006-2952(98)00050-1","journal-title":"Biochem Pharmacol"},{"key":"2582_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1099\/vir.0.013078-0","volume":"91","author":"MA Beale","year":"2010","unstructured":"Beale MA, Ijaz S, Tedder RS: The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants. J Gen Virol 2010, 91: 68-73. 10.1099\/vir.0.013078-0","journal-title":"J Gen Virol"},{"key":"2582_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/jac\/dkn014","volume":"61","author":"J Sheldon","year":"2008","unstructured":"Sheldon J, Soriano V: Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother 2008, 61: 766-768. 10.1093\/jac\/dkn014","journal-title":"J Antimicrob Chemother"},{"key":"2582_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-9-82","volume":"9","author":"Y Yong-Lin","year":"2012","unstructured":"Yong-Lin Y, Qiang F, Ming-Shun Z, Jie C, Gui-Ming M, Zu-Hu H, Xu-Bing C: Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J 2012, 9: 82. 10.1186\/1743-422X-9-82","journal-title":"Virol J"},{"key":"2582_CR14","doi-asserted-by":"publisher","first-page":"e67606","DOI":"10.1371\/journal.pone.0067606","volume":"8","author":"J Ma","year":"2013","unstructured":"Ma J, Zhang Y, Chen X, Jin Y, Chen D, Wu Y, Cui J, Wang H, Liu J, Li N, Gao F: Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients. PloS one 2013, 8: e67606. 10.1371\/journal.pone.0067606","journal-title":"PloS one"},{"key":"2582_CR15","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1128\/AAC.01499-06","volume":"51","author":"N Warner","year":"2007","unstructured":"Warner N, Locarnini S, Kuiper M, Bartholomeusz A, Ayres A, Yuen L, Shaw T: The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother 2007, 51: 2285-2292. 10.1128\/AAC.01499-06","journal-title":"Antimicrob Agents Chemother"},{"key":"2582_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.22796","volume":"49","author":"S Kamili","year":"2009","unstructured":"Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K: Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model. Hepatology 2009, 49: 1483-1491. 10.1002\/hep.22796","journal-title":"Hepatology"},{"key":"2582_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/S0037-86822010000300002","volume":"43","author":"R Haddad","year":"2010","unstructured":"Haddad R, Martinelli Ade L, Uyemura SA, Yokosawa J: Hepatitis B virus genotyping among chronic hepatitis B patients with resistance to treatment with lamivudine in the city of Ribeirao Preto, State of Sao Paulo. Rev Soc Bras Med Trop 2010, 43: 224-228. 10.1590\/S0037-86822010000300002","journal-title":"Rev Soc Bras Med Trop"},{"key":"2582_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1440-1746.2007.05238.x","volume":"23","author":"M Bottecchia","year":"2008","unstructured":"Bottecchia M, Ikuta N, Niel C, Araujo NM OKM, Gomes SA: Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B virus associated with a fatal hepatic failure case. J Gastroenterol Hepatol 2008, 23: 67-72. 10.1111\/j.1440-1746.2007.04912.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2582_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1590\/S0074-02762006000600013","volume":"101","author":"MV Sucupira","year":"2006","unstructured":"Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA: Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 2006, 101: 655-660.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2582_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1590\/S0074-02762010000600007","volume":"105","author":"AC Silva","year":"2010","unstructured":"Silva AC, Spina AM, Lemos MF, Oba IT, Guastini Cde F, Gomes-Gouvea MS, Pinho JR, Mendes-Correa MC: Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus\/hepatitis B virus co-infected patients in Brazil. Mem Inst Oswaldo Cruz 2010, 105: 770-778. 10.1590\/S0074-02762010000600007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2582_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/jmv.21845","volume":"82","author":"MC Mendes-Correa","year":"2010","unstructured":"Mendes-Correa MC, Pinho JR, Locarnini S, Yuen L, Sitnik R, Santana RA, Gomes-Gouvea MS, Leite OM, Martins LG, Silva MH, et al.: High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B. J Med Virol 2010, 82: 1481-1488. 10.1002\/jmv.21845","journal-title":"J Med Virol"},{"key":"2582_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.gastro.2012.05.002","volume":"143","author":"MW Lai","year":"2012","unstructured":"Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT: Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology 2012, 143: 400-407. 10.1053\/j.gastro.2012.05.002","journal-title":"Gastroenterology"},{"key":"2582_CR23","first-page":"695859","volume":"2011","author":"FC Mello","year":"2011","unstructured":"Mello FC, Martel N, Gomes SA, Araujo NM: Expression of hepatitis B virus surface antigen containing Y100C variant frequently detected in occult HBV infection. Hepat Res Treat 2011, 2011: 695859.","journal-title":"Hepat Res Treat"},{"key":"2582_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jhep.2012.01.005","volume":"56","author":"G Billioud","year":"2012","unstructured":"Billioud G, Pichoud C, Parent R, Zoulim F: Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants. J Hepatol 2012, 56: 1269-1275. 10.1016\/j.jhep.2012.01.005","journal-title":"J Hepatol"},{"key":"2582_CR25","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","volume":"137","author":"F Zoulim","year":"2009","unstructured":"Zoulim F, Locarnini S: Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009, 137: 1593-1608. e1591-1592 10.1053\/j.gastro.2009.08.063","journal-title":"Gastroenterology"},{"key":"2582_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S0036-46652000000400003","volume":"42","author":"LC Da Silva","year":"2000","unstructured":"Da Silva LC, da Fonseca LE, Carrilho FJ, Alves VA, Sitnik R, Pinho JR: Predictive factors for response to lamivudine in chronic hepatitis B. Rev Inst Med Trop Sao Paulo 2000, 42: 189-196.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2582_CR27","first-page":"95","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT1999. Nucleic Acids Symp 1999, 41: 95-98.","journal-title":"Nucleic Acids Symp"},{"key":"2582_CR28","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","volume":"24","author":"K Tamura","year":"2007","unstructured":"Tamura K, Dudley J, Nei M, Kumar S: MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24: 1596-1599. 10.1093\/molbev\/msm092","journal-title":"Mol Biol Evol"},{"key":"2582_CR29","volume-title":"Minitab handbook: updated for release 16","author":"B Ryan","year":"2012","unstructured":"Ryan B: Minitab handbook: updated for release 16. 6th edition. Boston, MA: Cengage; 2012.","edition":"6"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:02:29Z","timestamp":1630612949000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-320","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]},"assertion":[{"value":"29 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"320"}}